Serum levels of cytokines in systemic lupus erythematosus. Association study in a Chinese population

被引:0
|
作者
Zhang, M. [1 ,2 ]
Xu, W. -D. [1 ,2 ]
Zhu, Y. [1 ,2 ]
Wen, P. -F. [1 ,2 ]
Leng, R. -X. [1 ,2 ]
Pan, H. -F. [1 ,2 ]
Ye, D. -Q. [1 ,2 ]
机构
[1] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei 230032, Anhui, Peoples R China
[2] Anhui Med Univ, Anhui Prov Lab Populat Hlth & Major Dis Screening, Hefei 230032, Anhui, Peoples R China
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2014年 / 73卷 / 03期
基金
中国国家自然科学基金;
关键词
Interleukins; Autoantibodies; Genetic polymorphism; Synovial membrane; Lupus nephritis; TNF-ALPHA; FAMILY CYTOKINES; GENE-EXPRESSION; EFFICACY; IL-10; CELLS; INTERLEUKIN-32; SUSCEPTIBILITY; POLYMORPHISMS; HYPERPLASIA;
D O I
10.1007/s00393-013-1274-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by abnormal production of autoantibodies and proinflammatory cytokines. The clear pathogenesis of SLE has not been fully elucidated. Cytokine-mediated immunity has been showed to be involved in the pathogenesis of SLE. The aim of this study was to investigate serum levels of cytokines (IL-19, IL-24, IL-26, IL-31, IL-32, IL-36) in SLE patients, in comparison with normal controls in a Chinese population. A total of 65 patients with SLE and 65 healthy volunteers were recruited for the current study. All serum levels of cytokines were measured by enzyme-linked immunosorbent assay (ELISA) kits. Serum levels of IL-19, IL-24, IL-26, IL-31, IL-32 and IL-36 in SLE patients were not significantly different from the normal controls (all p > 0.05). Serum levels of IL-19, IL-24, IL-26, IL-31, IL-32 and IL-36 in SLE patients were not markedly different from the normal controls. However, functional research should be discussed in future studies to elucidate the roles of these cytokines in SLE.
引用
收藏
页码:277 / 280
页数:4
相关论文
共 50 条
  • [21] Genetics and systemic lupus erythematosus.
    Grossman J.M.
    Tsao B.P.
    Current Rheumatology Reports, 2000, 2 (1) : 13 - 18
  • [22] Biomarkers in systemic lupus erythematosus.
    Illei G.G.
    Lipsky P.E.
    Current Rheumatology Reports, 2004, 6 (5) : 382 - 390
  • [23] Neuropsychiatric systemic lupus erythematosus.
    Harten, P
    AKTUELLE RHEUMATOLOGIE, 1996, 21 (02) : 77 - 88
  • [24] Pregnancy in systemic lupus erythematosus.
    Abe, K
    Hashimoto, H
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S179 - S179
  • [25] Thalidomide in systemic lupus erythematosus.
    Vazquez-Cobian, LB
    Onel, KB
    Lehman, TJA
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S588 - S589
  • [26] Disability in systemic lupus erythematosus.
    Petri, M
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S129 - S129
  • [27] Autoantibodies in systemic lupus erythematosus.
    Hiepe, F
    Riemekasten, G
    Dorner, T
    AKTUELLE RHEUMATOLOGIE, 1996, 21 (02) : 62 - 71
  • [28] Genetics and systemic lupus erythematosus.
    Tsao B.P.
    Grossman J.M.
    Current Rheumatology Reports, 2001, 3 (3) : 183 - 190
  • [29] Dysregulated Serum Cytokines in Association with Clinical Manifestations in Patients with Systemic Lupus Erythematosus
    Seridi, Loqmane
    Leonardo, Steven
    Scott, Brittney
    Gordon, Robert
    Shu, Cathye
    Fei, Kaiyin
    Lo, Kim
    Stevens, Anne
    Gao, Sheng
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3055 - 3056
  • [30] Pleurisy in systemic lupus erythematosus.
    Petri, M
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S607 - S608